Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing

Eleven new investors participated in the round, including funds managed by . "This group of leading biotech investors recognizes the potential of our cell signaling platform for achieving the full promise of cell therapy," said Bellicum CEO .

http://ift.tt/1AbZqyz